![Justin Xiang](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Justin Xiang active positions
Companies | Position | Start | End |
---|---|---|---|
Seaport Diagnostics, Inc.
![]() Seaport Diagnostics, Inc. BiotechnologyHealth Technology Seaport Diagnostics, Inc. operates as a biotechnology company which develops treatments for genetically inherited diseases. It also offers DNA Tests for consumers across many categories such as nutrition, fitness, behavior tendencies, skincare, and more; provides consumers access to genetic information via mobile application; and manages human cell bank for future testing on regenerative medical therapies. The company was founded by Scott Schaus, Robin Y. Smith and Kate Blanchard on June 30, 2014 and is headquartered in Boston, MA. | Director/Board Member | - | - |
Syno Partners LLC
![]() Syno Partners LLC Investment ManagersFinance Syno Partners LLC (Syno Partners) is a venture capital firm founded in 2015 by Justin Xiang and Joseph Weilgus. The firm is headquartered in New York. | Chief Investment Officer | 01/01/2015 | - |
Founder | 01/01/2015 | - |
Career history of Justin Xiang
Former positions of Justin Xiang
Companies | Position | Start | End |
---|---|---|---|
LUNGLIFE AI, INC. | Director/Board Member | - | 01/07/2021 |
Statistics
International
United States | 3 |
China | 2 |
Operational
Director/Board Member | 2 |
Chief Investment Officer | 1 |
Founder | 1 |
Sectoral
Health Technology | 2 |
Health Services | 2 |
Finance | 2 |
Positions held
Active
Inactive
Listed companies
Private companies
Linked companies
Listed companies | 1 |
---|---|
LUNGLIFE AI, INC. | Health Services |
Private companies | 2 |
---|---|
Seaport Diagnostics, Inc.
![]() Seaport Diagnostics, Inc. BiotechnologyHealth Technology Seaport Diagnostics, Inc. operates as a biotechnology company which develops treatments for genetically inherited diseases. It also offers DNA Tests for consumers across many categories such as nutrition, fitness, behavior tendencies, skincare, and more; provides consumers access to genetic information via mobile application; and manages human cell bank for future testing on regenerative medical therapies. The company was founded by Scott Schaus, Robin Y. Smith and Kate Blanchard on June 30, 2014 and is headquartered in Boston, MA. | Health Technology |
Syno Partners LLC
![]() Syno Partners LLC Investment ManagersFinance Syno Partners LLC (Syno Partners) is a venture capital firm founded in 2015 by Justin Xiang and Joseph Weilgus. The firm is headquartered in New York. | Finance |
- Stock Market
- Insiders
- Justin Xiang
- Experience